Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits
- PMID: 8049202
- DOI: 10.1161/01.atv.14.8.1386
Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits
Abstract
The diet of Watanabe heritable hyperlipidemic (WHHL) rabbits was supplemented with a low dose (0.025% [wt/wt]) of the antioxidant vitamin E or probucol. The effect of 6 months of treatment on the susceptibility of low-density lipoproteins (LDLs) to oxidative modification and on established atherosclerotic lesions was studied. Vitamin E administration had no effect on plasma lipid levels; probucol supplementation decreased plasma total cholesterol. Vitamin E levels in plasma and LDL increased threefold in the course of treatment with this antioxidant. Six months of treatment with vitamin E and probucol increased the lag time of conjugated-diene formation of LDL subjected to in vitro oxidation by 54% (P < .001) and 51% (P = .019), respectively. In this LDL-oxidizability assay, only vitamin E reduced the maximal rate of conjugated-diene production (-24%, P < .001). Neither vitamin E treatment nor probucol therapy reduced the amount of thiobarbituric acid-reactive substances in plasma. Vitamin E treatment reduced the specific LDL apolipoprotein B-100 fluorescence (-10%, P = .035) compared with controls. Probucol was without effect on this index of in vivo LDL oxidation. At the end of the 6-month study, the mean +/- SD percentage area of aorta covered with plaques was 58.7 +/- 10.1% in control animals, 62.7 +/- 12.0% in the probucol-treated animals, and 48.9 +/- 13.8% in the animals treated with vitamin E; these differences were not significant. This study demonstrates that at this low dosage, vitamin E is a more effective antioxidant than probucol.
Similar articles
-
Vitamin E and fatty acid intervention does not attenuate the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits.Arterioscler Thromb Vasc Biol. 1995 Feb;15(2):290-7. doi: 10.1161/01.atv.15.2.290. Arterioscler Thromb Vasc Biol. 1995. PMID: 7749837
-
Probucol selectively increases oxidation of atherogenic lipoproteins in cholesterol-fed mice and in Watanabe heritable hyperlipidemic rabbits.Atherosclerosis. 1999 Jan;142(1):169-78. doi: 10.1016/s0021-9150(98)00234-2. Atherosclerosis. 1999. PMID: 9920518
-
The effect of vitamin E, probucol, and lovastatin on oxidative status and aortic fatty lesions in hyperlipidemic-diabetic hamsters.Atherosclerosis. 2000 Apr;149(2):277-86. doi: 10.1016/s0021-9150(99)00331-7. Atherosclerosis. 2000. PMID: 10729377
-
Role of biologically modified low-density lipoprotein in atherosclerosis.Am J Cardiol. 1989 Oct 3;64(13):18G-22G. doi: 10.1016/0002-9149(89)90951-x. Am J Cardiol. 1989. PMID: 2679026 Review.
-
Effect of supplementation with vitamin E on LDL oxidizability and prevention of atherosclerosis.Biofactors. 1998;7(1-2):51-4. doi: 10.1002/biof.5520070108. Biofactors. 1998. PMID: 9523028 Review.
Cited by
-
l-Citrulline and l-arginine supplementation retards the progression of high-cholesterol-diet-induced atherosclerosis in rabbits.Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13681-6. doi: 10.1073/pnas.0506595102. Epub 2005 Sep 12. Proc Natl Acad Sci U S A. 2005. PMID: 16157883 Free PMC article.
-
Clinical trials of vitamin E in coronary artery disease: is it time to reconsider the low-density lipoprotein oxidation hypothesis?Curr Atheroscler Rep. 2003 Mar;5(2):83-7. doi: 10.1007/s11883-003-0075-1. Curr Atheroscler Rep. 2003. PMID: 12573190 Review.
-
Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits.J Clin Invest. 1995 Oct;96(4):2075-82. doi: 10.1172/JCI118256. J Clin Invest. 1995. PMID: 7560102 Free PMC article.
-
Factors affecting resistance of low density lipoproteins to oxidation.Lipids. 1996 Mar;31 Suppl:S71-6. doi: 10.1007/BF02637054. Lipids. 1996. PMID: 8729097
-
Is lipid peroxidation relevant to atherogenesis?J Clin Invest. 1999 Jul;104(2):135-6. doi: 10.1172/JCI7633. J Clin Invest. 1999. PMID: 10411541 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical